European Medicines Agency appeals Brexit “frustration” ruling

EMA Canary Wharf

The European Medicines Agency (EMA) has appealed the High Court’s ruling that Brexit did not amount to the legal “frustration” of its £500m, 25-year lease with Canary Wharf Group.

The agency was given leave to appeal last month and submitted its appeal just before its deadline on Monday 15 April.

This is premium content

You must be logged in to view premium stories.

Gated access promo

Subscribe for full access

Take out a print and online or online only subscription and you will get immediate access to:

  • Breaking industry news as it happens
  • Expert analysis and comment from industry leaders
  • Unlimited access to all stories, including premium content
  • Full access to all our online archive

To get access to premium content subscribe today

Alternatively REGISTER for a free trial to access up to 4 articles and sign up for email alerts

If you are already a registered user or a subscriber you can SIGN IN now